Profil
F.
Michael Yakes worked as a Senior Director at Exelixis, Inc. from 2012 to 2012.
Prior to that, he worked as a Senior Director-Translational Biology at Cleave Therapeutics, Inc. Yakes holds a doctorate degree from Wayne State University (Michigan) and an undergraduate degree from Northern Michigan University.
Anciens postes connus de F. Michael Yakes
| Sociétés | Poste | Fin |
|---|---|---|
| EXELIXIS, INC. | Corporate Officer/Principal | 01/01/2012 |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Formation de F. Michael Yakes
| Wayne State University (Michigan) | Doctorate Degree |
| Northern Michigan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
